| Price | 10.25p on 08-12-2025 at 17:55:09 |
|---|---|
| Change | -1.00p -8.7% |
| Buy | 10.50p |
| Sell | 10.00p |
| Last Trade: | Buy 8,319.00 at 10.50p |
| Day's Volume: | 4,496,875 |
| Last Close: | 10.50p |
| Open: | 11.50p |
| ISIN: | GB00BYV81293 |
| Day's Range | 10.50p - 11.35p |
| 52wk Range: | 2.20p - 12.35p |
| Market Capitalisation: | £111.49m |
| VWAP: | 10.76691p |
| Shares in Issue: | 1.06b |
Sector: Medicine and Biotech
Listed In: FTSE AIM All-Share,
Shield Thera (STX) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Buy* | 8,319 | 10.50p | Suspected BUY Trade |
16:35:17 - 08-Dec-25 |
| Buy* | 5,000 | 10.35p | Ordinary |
16:29:45 - 08-Dec-25 |
| Buy* | 19,378 | 10.30p | Ordinary |
16:29:27 - 08-Dec-25 |
| Sell* | 68,895 | 10.13p | Ordinary |
16:29:26 - 08-Dec-25 |
| Buy* | 96,465 | 10.3623p | Ordinary |
16:25:58 - 08-Dec-25 |
| Buy* | 192,100 | 10.40p | Ordinary |
16:25:06 - 08-Dec-25 |
| Sell* | 5,000 | 10.00p | SI Trade |
16:23:37 - 08-Dec-25 |
| Sell* | 280 | 10.00p | SI Trade |
16:23:37 - 08-Dec-25 |
| Buy* | 5,000 | 10.50p | SI Trade |
16:23:37 - 08-Dec-25 |
| Buy* | 98,000 | 10.20p | Ordinary |
16:22:43 - 08-Dec-25 |
Shield Thera (STX) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 3rd Dec 2025 7:04 am | RNS | Amends Senior Secured Debt Financing |
| 14th Nov 2025 7:03 am | RNS | Initiation of a Phase II Clinical Trial in Japan |
| 11th Nov 2025 7:00 am | RNS | ACCRUFeR Pediatric PK Results to be Presented |
| 7th Nov 2025 7:03 am | RNS | ACCRUFeR receives Authorisation by Korean Ministry |
| 23rd Oct 2025 7:00 am | RNS | Q3 2025 Trading Update |
| 14th Oct 2025 3:01 pm | RNS | Grant of Share Options to Chief Executive Officer |
| 1st Oct 2025 8:00 am | RNS | Total Voting Rights |
| 1st Oct 2025 7:02 am | RNS | Positive efficacy and tolerance in pediatric trial |
| 15th Sep 2025 7:00 am | RNS | £1.5 million placing supporting growth of ACCRUFeR |
| 4th Sep 2025 7:03 am | RNS | ACCRUFeR® assigned Priority Review in US by FDA |
